Pharmalorraine SA
3.8 FTEPharmalorraine reported total assets of €2.26m at the end of the 2025 financial year (annual accounts filed with the NBB on 20 Aug 2026), with 3.8 full-time equivalents.
The score of Pharmalorraine shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +25 % Total assets +20 % Headcount (avg FTE) +3 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharmalorraine's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 20 Aug 2026
- Year ended 31 Dec 2024filed on 20 May 2025
- Year ended 31 Dec 2023filed on 19 Aug 2024
- Year ended 31 Dec 2022filed on 25 Jul 2023
- Year ended 31 Dec 2021filed on 18 Aug 2022
Pharmalorraine's financial analysis
- Solvency71.9%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharmalorraine
Pharmalorraine's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0455.089.059
- VAT number
- BE0455089059
- Peppol
- Registered · 0208:0455089059 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 20 Apr 1995
- Registered office
- 6790 Aubange
- Size
- Micro · 3.8 FTE
- Latest accounts
- 2025 · filed on 20 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Pharmalorraine (SA) has been based in Aubange since 1995, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 115,026 € and equity of €1.62m; its revenue is not published. With 3.8 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 71.9%, above the median of its sector (41.5%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Pharmalorraine
Companies in the same business, of comparable size and area, outside its group.
- Molleman - de Coster Retail sale of pharmaceutical products Wingene · balance sheet €2.22m
- Apotheek Verhoeve - Vasbinder Retail sale of pharmaceutical products Tielt · balance sheet €2.09m
- Romapharm Retail sale of pharmaceutical products Koksijde · balance sheet €2.97m
- Pharmacie L BRICLET Retail sale of pharmaceutical products Charleroi · balance sheet €2.03m
- Farcas Retail sale of pharmaceutical products Gavere · balance sheet €1.64m
- Phaverso Retail sale of pharmaceutical products Moorslede · balance sheet €3.28m
- Unidose Pharma Retail sale of pharmaceutical products Izegem · balance sheet €3.90m
- Fagedis Retail sale of pharmaceutical products Seneffe · balance sheet €1.29m
Frequently asked questions about Pharmalorraine
What is the revenue of Pharmalorraine?
Pharmalorraine files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharmalorraine?
In Belgium, the VAT number is the company number prefixed with BE: BE0455089059 for Pharmalorraine, if the company is VAT-registered. Its company number (CBE) is 0455.089.059.
Where is the registered office of Pharmalorraine?
According to the CBE register, the registered office of Pharmalorraine is in 6790 Aubange.
What is the equity of Pharmalorraine?
At the close of the 2025 financial year, the equity of Pharmalorraine amounts to 1,624,723 €, a solvency of 71.9% of total assets.
How many people work at Pharmalorraine?
3.8 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Pharmalorraine?
The register lists 4 active mandates at Pharmalorraine. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharmalorraine
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →